Blog
Health Canada Compliance Insights
NHPD testing guides, Canadian regulatory updates, and compliance insights for natural health product manufacturers, supplement brands, and Amazon Canada sellers.
Drug Serialization in Canada: The Traceability Requirements Your Pharma Supply Chain Cannot Ignore
Canada has no DSCSA equivalent yet — but Health Canada GMP, US export obligations, and hospital buyer pressure are closing the traceability gap fast.
Clinical Trial Application in Canada: How the CTA Process Works Under Division 5 of the Food and Drug Regulations
Learn how Canada's CTA process works under Division 5 of the Food and Drug Regulations — timelines, package requirements, and common NON-C triggers.
Canada GMP for Clinical Trial Materials: What Sponsors, CROs, and CMOs Need to Know
Health Canada's GMP requirements for clinical trial materials are stricter than most sponsors expect. Here's what the C.02 framework actually demands before you file a CTA.
Canada GMP's Qualified Person Responsible for Release: What Health Canada Expects From Your Lot Release Program
A deep dive into the QPRR role under Canada GMP regulations — C.02.014 requirements, qualifications, CMO considerations, and what Health Canada inspectors flag.
PBRER Submissions to Health Canada: What Drug Sponsors Get Wrong About Periodic Pharmacovigilance Reporting
Health Canada's PBRER requirements under ICH E2C(R2) differ meaningfully from FDA and EMA submissions. Here's what Canadian drug sponsors consistently miss.
Pharmacovigilance in Canada: What Drug Sponsors Must Report After Market Authorization
A practical guide to Health Canada pharmacovigilance obligations — adverse reaction timelines, PBRER requirements, and Vanessa's Law penalties for marketed drug sponsors.
CMO Qualification Audits Under Canada GMP: What to Verify Before You Outsource Manufacturing
Before outsourcing pharmaceutical manufacturing in Canada, you need a documented CMO qualification program. Here's what Health Canada GMP actually requires.
Schedule A Under Canada's Natural Health Products Regulations: The Disease Claim Rules That Keep Catching NPN Holders Off Guard
Schedule A of Canada's Food and Drugs Act prohibits disease claims on NHP labels and marketing. Here's what Canadian manufacturers keep getting wrong.
Cell and Gene Therapy Approval in Canada: What Health Canada's BGTD Pathway Actually Requires
A technical guide for sponsors developing cell and gene therapies in Canada — covering Health Canada's BGTD review pathway, GMP for viral vectors and autologous products, and realistic CTA-to-NOC timelines.
ICH E6(R3) and Risk-Based Monitoring: What Canadian Clinical Trial Sponsors Actually Need to Update
ICH E6(R3) finalized in 2023 reshaped GCP compliance. Here's what Canadian sponsors and CROs must update now to meet Health Canada's evolving expectations.
Electronic Lab Notebooks Under Canada GMP: What Health Canada's Data Integrity Guidelines Actually Require
Learn what Health Canada GMP guidelines require for electronic lab notebooks — ALCOA+, CSV, audit trails, and what inspectors flag during audits.
Computerized System Validation Under Canada GMP: What Health Canada Inspectors Actually Expect
Health Canada GMP requires validated computerized systems — here's what inspectors actually check, from GAMP 5 classification to data integrity controls.
Why NPN Applications Fail: Common Deficiencies Under Canada's Natural Health Products Regulations
Most NPN rejections aren't bad science — they're avoidable deficiencies. Learn what Canada's Natural Health Products Regulations actually require before you submit.
NHP Site Licence Amendments in Canada: When You're Required to Notify Health Canada
Under Canada's Natural Health Products Regulations, dozens of operational changes trigger a mandatory site licence amendment. Here's what qualifies and how to file correctly.
Real-World Evidence in Health Canada Drug Submissions: What Canadian Pharmaceutical Sponsors Actually Need to Know
Real-world evidence is reshaping Canadian drug submissions. What Health Canada expects from RWE data packages, and where most Canadian sponsors get it wrong.
Technology Transfer Between Canadian CROs and CMOs: What Health Canada GMP Actually Requires
What Health Canada GMP requires during technology transfer from a CRO to a CMO — covering ICH Q10, analytical method comparability, and protocol structure.
Process Analytical Technology Under Canada GMP: What Health Canada's PAT Framework Actually Means for Manufacturers
A technical guide to implementing PAT under Canada GMP guidelines — covering Health Canada's ICH alignment, GUI-0029 validation expectations, and real-time release testing.
Container Closure Integrity Testing Under Canada GMP: Methods, Standards, and What Health Canada Inspectors Expect
A technical guide to CCIT method selection, validation, and Health Canada GMP compliance for Canadian sterile drug manufacturers and CROs.